Metastatic Breast Cancer, Triple Negative Breast Cancer Completed Phase 1 Trials for Sonidegib (DB09143)

Also known as: Metastatic Triple-negative Breast Cancer / Metastatic Triple Negative Breast Cancer / Triple-negative Metastatic Breast Cancer / Triple Negative Metastatic Breast Cancer

IndicationStatusPhase
DBCOND0074793 (Metastatic Breast Cancer, Triple Negative Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01576666Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsOther